治疗性噬菌体监测:综述
随着全球抗菌药物耐药性上升,治疗性噬菌体应用重新受到关注。本文提出治疗性噬菌体监测(TPM)是噬菌体治疗(PT)方案的必要组成部分,通过监测血液和组织中噬菌体浓度、免疫反应及生态变化,可能实现剂量优化和精准医学,并可验证疗效替代指标、指导研究和建立产品质量保证指标。
要点
- TPM被提议为噬菌体治疗方案的必要元素,用于填补体内疗效、免疫反应和生态效应方面的知识空白。
- 监测血液和组织中噬菌体浓度、免疫反应及生态变化,可能实现剂量优化和精准医学。
- TPM可验证疗效诊断替代指标、指导研究方向并建立治疗性噬菌体产品的质量保证指标。
核心结论
- TPM在增强对噬菌体-细菌-宿主多向相互作用的理解和推进「最佳实践」噬菌体治疗方面具有巨大潜力,最终改善患者护理。
研究设计与样本
- 本文为综述,检索范围原文未报告。
主要发现
- TPM通过监测血液和组织中噬菌体浓度、免疫反应及可能的生态变化,可能实现剂量优化和精准医学。
- TPM可验证疗效诊断替代指标、指导研究努力并建立治疗性噬菌体产品的质量保证指标。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With the global rise in antimicrobial resistance, there has been a renewed interest in the application of therapeutic phages to treat bacterial infections. Therapeutic phage monitoring (TPM) is proposed as an essential element of phage therapy (PT) protocols to generate data and fill knowledge gaps regarding the in vivo efficacy of therapeutic phages, patients' immune responses to PT, and the wider ecological effects of PT. By monitoring phage concentrations in blood and tissues, together with immune responses and possible ecological changes during PT, TPM may enable the optimization of dosing and the implementation of precision medicine approaches. Furthermore, TPM can validate diagnostic surrogates of efficacy, direct research efforts, and establish quality assurance indicators for therapeutic phage products. Thus, TPM holds great potential for enhancing our understanding of the multidirectional phage-bacteria-host interactions and advancing "best practice" PT, ultimately improving patient care.
引用
- Bosco K, Lynch S, Sandaradura I, et al. Therapeutic Phage Monitoring: A Review. Clin Infect Dis. 2023. PMID: 37932121. doi:10.1093/cid/ciad497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。